News tagged with biomed central

Related topics: breast cancer , protein

Whole genome or exome sequencing: An individual insight

Focusing on parts rather than the whole, when it comes to genome sequencing, might be extremely useful, finds research in BioMed Central's open access journal Genome Medicine. The research compares several sequencing techno ...

Jun 27, 2013
popularity 5 / 5 (2) | comments 0 | with audio podcast

The protein profile of restless leg syndrome

A protein profile of people with restless leg syndrome (RLS), identifies factors behind disrupted sleep, cardiovascular dysfunction and pain finds research in BioMed Central's open access journal Fluids and Barriers of th ...

Jun 06, 2013
popularity not rated yet | comments 0

Is enough being done to make drinking water safe?

There is a lack of evidence regarding the effectiveness of technologies used to reduce arsenic contamination finds research in BioMed Central's open access journal Environmental Evidence. More studies assessing the techno ...

May 30, 2013
popularity not rated yet | comments 0

Women's immune systems remain younger for longer

Women's immune systems age more slowly than men's, suggests research in BioMed Central's open access journal Immunity & Ageing. The slower decline in a woman's immune system may contribute to women living longer than men. ...

May 14, 2013
popularity not rated yet | comments 0

The risks of H7N9 infection mapped

A map of avian influenza (H7N9) risk is presented in Biomed Central's open access journal Infectious Diseases of Poverty today. The map is comprised of bird migration patterns, and adding in estimations of poultry production ...

May 03, 2013
popularity not rated yet | comments 0

Clarifying the effect of stem cell therapy on cancer

Injection of human stem cells into mice with tumors slowed down tumor growth, finds research published in BioMed Central's open access journal Stem Cell Research & Therapy. Human mesenchymal stem cells (MSC), isolated from b ...

Apr 29, 2013
popularity 5 / 5 (1) | comments 0

BioMed Central

BioMed Central (BMC) is a UK-based for-profit scientific publisher specializing in open access publication. BMC publishes over 180 scientific journals, and describes itself as the first and largest open access science publisher. BMC sister companies publish the Chemistry Central and PhysMath Central journals. The Chairman is Vitek Tracz and the Publisher is Matt Cockerill.

Most titles are open access, including its flagship journals Journal of Biology, Molecular Cancer Malaria Journal, the innovative Journal of Negative Results in BioMedicine and the BMC journal series including the leading titles BMC Biology and BMC Medicine. Others are open access for the research articles portion only, such as Genome Biology, Arthritis Research & Therapy, Breast Cancer Research, andCritical Care. Some review titles, such as Current Opinion in Drug Discovery & Development are entirely subscription based. Open access content is released under the Creative Commons "Attribution" license which grants permission to reuse publications and produce derivative work.

In October 2008, it was announced that BMC, Chemistry Central, and PhysMath Central, had been acquired by Springer Science+Business Media. Previously, since its creation, the company was part of Science Navigation Group, chaired by Vitek Tracz, which also owns The Scientist (a popular science magazine—the daily news section is free access; the remainder is by subscription), Faculty of 1000 (a subscription-only current awareness service highlighting recent biological research), Global DataPoint, People's Archive and, in the past, two other companies which had previously been acquired by Springer, Images.MD (a medical image database) and Current Medicine.

In November 2008, BMC became an official supporting organisation of HIFA2015 (Healthcare Information For All by 2015).

This text uses material from Wikipedia licensed under CC BY-SA